Determination of rat vertebral bone compressive fatigue properties in untreated intact rats and zoledronic-acid-treated, ovariectomized rats

[1] Wu K(1967)Bone resorption rates in rib in physiological, senile, and postmenopausal osteoporoses J Lab Clin Med 69 810-818

[2] Jett S(1969)Bone formation in osteoporosis. Appositional rate measured by tetracycline labeling Arch Pathol 88 508-510

[3] Frost HM(1974)The role of fatigue in the pathogenesis of senile femoral neck fractures J Bone Joint Surg Br 56-B 698-702

[4] Wu K(1995)The worldwide problem of osteoporosis: insights afforded by epidemiology Bone 17 S505-S511

[5] Frost HM(2006)Preservation of thoracic spine microarchitecture by alendronate: comparison of histology and microCT Bone 38 444-449

[6] Freeman MA(2006)Ibandronate: pharmacology and preclinical studies Bone 38 S7-S12

[7] Todd RC(2004)Risedronate preserves bone architecture in postmenopausal women with osteoporosis as measured by three-dimensional microcomputed tomography Bone 34 736-746

[8] Pirie CJ(2007)Bisphosphonate efficacy and clinical trials for postmenopausal osteoporosis: similarities and differences Bone 40 S26-S31

[9] Riggs BL(2004)Postmenopausal osteoporosis and alendronate Maturitas 48 179-192

[10] Melton LJ(2001)Comparison of calcitonin, alendronate and fluorophosphate effects on ovariectomized rat bone Biomed Pharmacother 55 397-403

[1] Wu K(1967)Bone resorption rates in rib in physiological, senile, and postmenopausal osteoporoses J Lab Clin Med 69 810-818

[2] Jett S(1969)Bone formation in osteoporosis. Appositional rate measured by tetracycline labeling Arch Pathol 88 508-510

[3] Frost HM(1974)The role of fatigue in the pathogenesis of senile femoral neck fractures J Bone Joint Surg Br 56-B 698-702

[4] Wu K(1995)The worldwide problem of osteoporosis: insights afforded by epidemiology Bone 17 S505-S511

[5] Frost HM(2006)Preservation of thoracic spine microarchitecture by alendronate: comparison of histology and microCT Bone 38 444-449

[6] Freeman MA(2006)Ibandronate: pharmacology and preclinical studies Bone 38 S7-S12

[7] Todd RC(2004)Risedronate preserves bone architecture in postmenopausal women with osteoporosis as measured by three-dimensional microcomputed tomography Bone 34 736-746

[8] Pirie CJ(2007)Bisphosphonate efficacy and clinical trials for postmenopausal osteoporosis: similarities and differences Bone 40 S26-S31

[9] Riggs BL(2004)Postmenopausal osteoporosis and alendronate Maturitas 48 179-192

[10] Melton LJ(2001)Comparison of calcitonin, alendronate and fluorophosphate effects on ovariectomized rat bone Biomed Pharmacother 55 397-403